Success! In Clinical Laboratory Science – Hemostasis Practice Test

Thrombin time measures the last step of coagulation: the conversion of fibrinogen into fibrin by thrombin. If this step is delayed, it points to problems with the fibrinogen itself or with thrombin activity. Dysfibrinogenemia means the fibrinogen molecule is defective and cannot be converted efficiently to fibrin, while low fibrinogen levels reduce substrate availability for thrombin; both prolong the thrombin time. Also, any thrombin inhibitor in the blood (such as heparin or a direct thrombin inhibitor) slows the action of thrombin, prolonging the thrombin time. Defects in factor VII or factor XII affect earlier pathways (extrinsic and intrinsic pathways) and typically alter prothrombin time or partial thromboplastin time, not the thrombin time. Deficiency of vitamin K–dependent factors disrupts initiation and amplification of coagulation and also tends to prolong PT/aPTT rather than the final fibrinogen-to-fibrin conversion, unless there’s an additional fibrinogen issue. Hence, a prolonged thrombin time most specifically points to a problem with fibrinogen function or the presence of thrombin inhibitors.